Form 8-K - Current report:
SEC Accession No. 0001564590-22-037633
Filing Date
2022-11-14
Accepted
2022-11-14 16:24:29
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20221114.htm   iXBRL 8-K 38315
2 EX-99.1 txmd-ex991_6.htm EX-99.1 606894
3 GRAPHIC ggvlijmmqc2s000001.jpg GRAPHIC 6973
4 GRAPHIC gvhotr4w5otc000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-22-037633.txt   819244

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA txmd-20221114.xsd EX-101.SCH 5613
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20221114_lab.xml EX-101.LAB 19320
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20221114_pre.xml EX-101.PRE 11504
9 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20221114_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 221386072
SIC: 2834 Pharmaceutical Preparations